product presentation
The density of
| 1.0 + / - 0.1 g/cm3
|
Boiling point
| 537.2±50.0 °C at 760 mmHg
|
Melting point DHS
| 33 to 37 C
|
Molecular formula
| C28H44O3
|
The molecular weight of
| 428.647
|
Flash point
| 226.8 + / - 30.2 ° C
|
Exact mass
| 428.329041
|
PSA
| 43.37000
|
LogP
| 8.14
|
Appearance and Properties
| White to light yellow powder
|
Vapor pressure
| 0.0±1.4 mmHg at 25°C
|
The refractive index of
| 1.525
|
The molecular structure
|
|
1, molar refractive index:
| 125.08
|
2.molar volume (CM3 /mol) :
| 408.3
|
3. Isotonic ratio (90.2K) :
| 1034.4
|
4, surface tension (Dyne /cm) :
| 41.2 |
5.Polarization (10-24cm3) : 49.58
company introduction
Hebei LinWo New Material Technology Co., LTD., located in Xingtai City, Hebei Province, is a professional biotechnology service enterprise engaged in biomedical technology services, technical consultation and product development. The company is committed to biotechnology, medical science and technology development, technical consultation; And pharmaceutical intermediates, chemical products and chemical raw materials (excluding hazardous chemicals) research and development, sales; Including cosmetic raw materials, food additives, feed additives, veterinary drugs, pesticides, flavors, pharmaceutical raw materials, chemical raw materials and other product technology as the core of the production, research and development; It also includes the import and export of goods and technology.
According to the initial formation of the production and processing of Chinese patent medicine, API, pharmaceutical intermediates, health medicine, medical devices and other products of the industrial development pattern, vigorously promote the construction of pharmaceutical and chemical industry base. Hebei province xingtai medicine chemical industry base has a certain scale, the industrial chain is more complete, upstream and downstream products of basic facilities, a sound marketing network, sales of products in the existing more than 50 new products in hebei province, the national new medicine 18, 17
China
